
PSB-603
CAS No. 1092351-10-4
PSB-603 ( PSB 603 )
产品货号. M27690 CAS No. 1092351-10-4
腺苷A2B受体拮抗剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3224 | 有现货 |
![]() ![]() |
10MG | ¥4795 | 有现货 |
![]() ![]() |
25MG | ¥7671 | 有现货 |
![]() ![]() |
50MG | ¥10368 | 有现货 |
![]() ![]() |
100MG | ¥14013 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PSB-603
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述腺苷A2B受体拮抗剂。
-
产品描述Adenosine A2B receptor antagonist.(In Vitro):In peripheral T cells, PSB-603 (100 nM) inhibits NECA-stimulated IL-6 release about 3-fold. PSB-603 (10 μM) shows no affinity for the human and rat A1 and A2A and human A3 receptors.(In Vivo):PSB-603 (5 mg/kg; i.p.) significantly reduces inflammation in local and systemic mice models of inflammation. In the inflamed paw, PSB-603 significantly decreases the levels of the inflammatory cytokines including IL-6, TNF-α and of ROS. PSB-603 reduces inflammation of the peritoneum by decreasing the infiltration of leukocytes.
-
体外实验PSB-603 is a potent and selective adenosine A2B receptor antagonist exhibiting a Ki value of 0.553 nM at the human A2B receptor and virtually no affinity for the human and rat A1 and A2A and the human A3 receptors up to a concentration of 10 μM. Cell Viability Assay Cell Line:Peripheral T cells Concentration:100 nM Incubation Time:24 hours Result:Significantly inhibited NECA stimulated IL-6 release ≈3-fold.
-
体内实验PSB-603 shows anti-inflammatory effect in local and systemic inflammation models. PSB-603 (5 mg/kg b.w. ip) significantly reduces inflammation in two mice models of inflammation (local and systemic). PSB-603 significantly decreases levels of the inflammatory cytokines IL-6, TNF-α and of ROS in the inflamed paw and reduces inflammation of the peritoneum by significantly decreasing the infiltration of leukocytes. PSB-603 is administered as suspensions in 1 % Tween 80. Animal Model:Adult male Albino Swiss mice, CD-1, weighing 25-30 g Dosage:1, 5 or 10 mg/kg Administration:Administered intraperitoneally (ip), prior to carrageenan injection Result:Carrageenan-induced edema model. The increase in paw oedema was significantly inhibited in all groups receiving PSB-603. The dose of 5 mg/kg turned out to be the most active.
-
同义词PSB 603
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number1092351-10-4
-
分子量529.01
-
分子式C24H25ClN6O4S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 32.5 mg/mL (61.44 mM)
-
SMILESCCCn1c(O)nc2nc([nH]c2c1=O)-c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(Cl)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Edward Scolnick, et al. Uses of paralog-selective inhibitors of gsk3 kinases. US20160375006A1.
产品手册




关联产品
-
Lucidenic acid SP1 (...
Lucidenic acid SP1 is a natural product.
-
threo-Guaiacylglycer...
Threo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
-
Uprosertib
Uprosertib (GSK2141795) 是一种选择性、ATP 竞争性、口服生物可利用的 Akt 抑制剂,对 Akt 1、2 和 3 的 IC50 值分别为 180 nM、328 nM 和 38 nM。